Capital Group Investment Management’s Gilead Sciences GILD Stock Holding History

Capital Group Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,666	Closed	-$800K	–	147
2024 Q4	$800K	Sell	8,666 -4,015	-32%	-$362K	0.15%	116
2024 Q3	$1.06M	Hold	12,681	–	–	0.21%	97
2024 Q2	$870K	Hold	12,681	–	–	0.19%	108
2024 Q1	$929K	Buy	12,681 +508	+4%	+$39.1K	0.17%	141
2023 Q4	$986K	Hold	12,173	–	–	0.1%	150
2023 Q3	$912K	Buy	12,173 +3,880	+47%	+$298K	0.06%	146
2023 Q2	$639K	Buy	+8,293	New	+$661K	0.03%	166

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Group Investment Management's GILD Position: Q1 2025 in Review

Capital Group Investment Management sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 8,666 shares — an estimated $800K sold.

Capital Group Investment Management first reported a position in GILD in Q2 2023 and held it in 7 quarters. The position peaked at $1.06M in Q3 2024. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Capital Group Investment Management reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
Capital Group Investment Management sold 8,666 Gilead Sciences shares in Q1 2025, an estimated $800K.
Capital Group Investment Management first reported a position in Gilead Sciences in Q2 2023 and held it in 7 quarters.
Capital Group Investment Management's Gilead Sciences position peaked at $1.06M in Q3 2024.
2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Capital Group Investment Management's 13F filing for Q1 2025, filed 12 May 2025.